
Alexander Cohen
Articles
-
Oct 4, 2024 |
nature.com | Shaoling Peng |Zaixu Cui |Alexander Cohen |Michael Fox
AbstractTask functional magnetic resonance imaging research has generally shielded away from studying individuals due to the low reproducibility. Here, we propose that heterogeneous brain activations across individuals localize to a common network. To test this hypothesis, we use working memory (WM) as our example. First, we showed that discrete-brain-based reproducibility of brain activation during WM across individuals was low.
-
Aug 26, 2024 |
cell.com | Alexander Cohen |Jennifer R. Keeffe |Sandra E. Dross |Allison J Greaney
Highlights • Pan-sarbecovirus vaccine evaluated in pre-vaccinated monkeys and mice • Mosaic nanoparticles elicited broad antibody responses after COVID-19 vaccinations • Epitope and molecular fate mapping revealed cross-reactive recall responses • Original antigenic sin did not diminish immune responses to a mosaic vaccine Summary Immunization with mosaic-8b (nanoparticles presenting 8 SARS-like betacoronavirus [sarbecovirus] receptor-binding domains [RBDs]) elicits more broadly...
-
May 22, 2024 |
biorxiv.org | Alexander Cohen |Jennifer R. Keeffe |Ariën Schiepers |Sandra E. Dross
AbstractImmunization with mosaic-8b [60-mer nanoparticles presenting 8 SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs)] elicits more broadly cross-reactive antibodies than homotypic SARS-CoV-2 RBD-only nanoparticles and protects against sarbecoviruses.
-
May 6, 2024 |
nature.com | Rory A Hills |Tiong Kit Tan |Alexander Cohen |Jennifer R. Keeffe |Michelle Hill |Madeeha Afzal | +7 more
AbstractDefending against future pandemics requires vaccine platforms that protect across a range of related pathogens. Nanoscale patterning can be used to address this issue. Here, we produce quartets of linked receptor-binding domains (RBDs) from a panel of SARS-like betacoronaviruses, coupled to a computationally designed nanocage through SpyTag/SpyCatcher links.
-
Apr 8, 2024 |
medrxiv.org | Rose Gelineau-Morel |Nomazulu Dlamini |Joel Bruss |Alexander Cohen
The authors have declared no competing interest. This work was supported by NIH NICHD T32HD069038 (RGM), The Auxilium Foundation (ND), NIMH K23MH120510 and the Simons Foundation Autism Research Initiative (AC), NIH NICHD P50 HD103525 (CDS), and NIH NINDS 3R01NS114405 (AB). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →